Morgan Stanley’s MiNK Therapeutics INKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $163 | Sell |
22
-2
| -8% | -$15 | ﹤0.01% | 7597 |
|
|
2025
Q1 | $208 | Sell |
24
-9
| -27% | -$78 | ﹤0.01% | 7468 |
|
|
2024
Q4 | $233 | Sell |
33
-1
| -3% | -$7 | ﹤0.01% | 7402 |
|
|
2024
Q3 | $252 | Sell |
34
-4
| -11% | -$30 | ﹤0.01% | 7367 |
|
|
2024
Q2 | $363 | Sell |
38
-22
| -37% | -$210 | ﹤0.01% | 7257 |
|
|
2024
Q1 | $545 | Sell |
60
-837
| -93% | -$7.6K | ﹤0.01% | 7232 |
|
|
2023
Q4 | $9.6K | Buy |
897
+87
| +11% | +$931 | ﹤0.01% | 6840 |
|
|
2023
Q3 | $8.91K | Sell |
810
-409
| -34% | -$4.5K | ﹤0.01% | 6771 |
|
|
2023
Q2 | $25.6K | Buy |
+1,219
| New | +$25.6K | ﹤0.01% | 6483 |
|
|
2023
Q1 | – | Sell |
-4
| Closed | -$107 | – | 7771 |
|
|
2022
Q4 | $107 | Hold |
4
| – | – | ﹤0.01% | 7691 |
|
|
2022
Q3 | $0 | Sell |
4
-42
| -91% | – | ﹤0.01% | 7792 |
|
|
2022
Q2 | $1K | Buy |
46
+37
| +411% | +$804 | ﹤0.01% | 7685 |
|
|
2022
Q1 | $0 | Sell |
9
-4,248
| -100% | – | ﹤0.01% | 8033 |
|
|
2021
Q4 | $189K | Buy |
+4,257
| New | +$189K | ﹤0.01% | 6107 |
|